APA引文

Barlas, S. (2016). Early Biosimilars Face Hurdles to Acceptance: The FDA Has Approved Few, So Lack of Competition Is Keeping Prices High. P T.

Citação norma Chicago

Barlas, Stephen. "Early Biosimilars Face Hurdles to Acceptance: The FDA Has Approved Few, So Lack of Competition Is Keeping Prices High." P T 2016.

MLA引文

Barlas, Stephen. "Early Biosimilars Face Hurdles to Acceptance: The FDA Has Approved Few, So Lack of Competition Is Keeping Prices High." P T 2016.

警告：這些引文格式不一定是100％准確.